Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
AZNX AstraZeneca tokenized stock (xStock)
Currency:
🇺🇸
USD
🇺🇸
USD - US Dollar
🇨🇳
CNH - Offshore Chinese Yuan
🇯🇵
JPY - Japanese Yen
🇰🇷
KRW - South Korean Won
🇭🇰
HKD - Hong Kong Dollar
🇦🇺
AUD - Australian Dollar
🇪🇺
EUR - Euro
🇨🇭
CHF - Swiss Franc
🇬🇧
GBP - British Pound
🇨🇦
CAD - Canadian Dollar
🌐
TWD - Taiwan Dollar
🇲🇾
MYR - Malaysian Ringgit
🇸🇬
SGD - Singapore Dollar
🇳🇿
NZD - New Zealand Dollar
$ 109.27
-$2.82
-2.58%
$112.14
24H High
$96.40
24H Low
$188.85
All-Time High
$72.92
All-Time Low
7.66K
24H Volume
$798.74K
24H Turnover
--
Total Supply
$61.87M
Market Cap
16.32%
24H Range
566.18K
Circ. Supply
--
Prev Open (UTC+8)
--
Prev Close (UTC+8)
--
Circulation Ratio
AZNXMarket
-
Trend
-
K-Line
AZNX Summary
AZNX represents AstraZeneca tokenized stock (xStock), a digital asset designed to mirror the value and trading of traditional AstraZeneca shares on a blockchain. This tokenization aims to provide investors with fractional ownership and increased accessibility to the equity markets, potentially lowering barriers to entry for global participants. By leveraging blockchain technology, tokenized stocks like AZNX can offer enhanced liquidity and transparency compared to conventional stock trading.
The underlying mechanism for AZNX typically involves a regulated entity or platform that holds the actual AstraZeneca shares in custody and issues corresponding tokens on a blockchain. Each AZNX token is backed by a proportional share of the underlying stock, ensuring that its value closely tracks the market performance of AstraZeneca. This structure allows for 24/7 trading, faster settlement times, and potentially reduced transaction costs, characteristic advantages of decentralized finance.
The primary use case for AZNX is to facilitate investment in AstraZeneca's equity through a digital asset format. It enables users to gain exposure to the pharmaceutical giant's stock performance without necessarily engaging with traditional brokerage firms or exchanges. This can appeal to a broad range of investors, including those in regions with limited access to international stock markets or those who prefer the efficiency and programmability of blockchain-based assets.
As a tokenized stock, AZNX occupies a niche within the evolving landscape of digital assets, bridging traditional finance with decentralized technology. Its market position is defined by its ability to offer a blockchain-native alternative for investing in established companies like AstraZeneca, contributing to the broader trend of asset tokenization and the convergence of traditional and digital financial systems.
The underlying mechanism for AZNX typically involves a regulated entity or platform that holds the actual AstraZeneca shares in custody and issues corresponding tokens on a blockchain. Each AZNX token is backed by a proportional share of the underlying stock, ensuring that its value closely tracks the market performance of AstraZeneca. This structure allows for 24/7 trading, faster settlement times, and potentially reduced transaction costs, characteristic advantages of decentralized finance.
The primary use case for AZNX is to facilitate investment in AstraZeneca's equity through a digital asset format. It enables users to gain exposure to the pharmaceutical giant's stock performance without necessarily engaging with traditional brokerage firms or exchanges. This can appeal to a broad range of investors, including those in regions with limited access to international stock markets or those who prefer the efficiency and programmability of blockchain-based assets.
As a tokenized stock, AZNX occupies a niche within the evolving landscape of digital assets, bridging traditional finance with decentralized technology. Its market position is defined by its ability to offer a blockchain-native alternative for investing in established companies like AstraZeneca, contributing to the broader trend of asset tokenization and the convergence of traditional and digital financial systems.
AZNXNews
All
Newsflash
Article
No related news
No related news
No related news
24H Trending
-
1
What is TAP? Does Tapioca DAO have investment potential in the future?
-
2
After five months of inactivity, the Step Finance attacker sold $21.4 million worth of SOL and transferred the funds to Tornado Cash
-
3
Speaker of the Iranian Parliament: Reaching a Consensus with the U.S. Is Possible
-
4
A trader opened a 15x leveraged short position on $2.39 million worth of BTC and incurred a lifetime loss of $389,700.
-
5
Bitget saw a net inflow of $743 million on the 7th, which may be related to the launch of rToken and U.S. stock trading features
-
6
Ethereum The Foundation awarded Argot its fourth-year grant, consisting of 2,469 stETH worth $4.34 million.
-
7
LinqAlpha Completes $22 Million Series A Funding Round, Led by AVP and Others
-
8
Over the past three days, the U.S. has escorted only 70 merchant ships through the Strait of Hormuz, down from the pre-conflict daily average of 138.
-
9
Michael Saylor Shares Another Update on the "Bitcoin" Tracker; Strategy May Disclose Data on Additional Purchases
-
10
Jamf: Fake "Maccy" Clipboard App Spreads New Mac Password-Stealing Malware Called PamStealer
Recommended Reading

